Procalcitonin Monitoring Sepsis Study

Completed

Conditions studied: Severe Sepsis, Septic Shock

In brief

The purpose of this study is to investigate the relationship between a procalcitonin decrease over 72 hours and outcome in patients who have severe sepsis or septic shock.

Key facts

Study ID

NCT01523717

Run by

Brahms AG

People needed

858

Starts

2011-12-01

Expected to finish

2014-03-01

Last updated by the study team

2015-03-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (i.e. >18 years of age) diagnosed with severe sepsis or septic shock as defined in Appendix 1, who are already in the ICU or come from the ED, other wards or directly from out of hospital
• Blood sample collection within 12 hours after diagnosis "severe sepsis or septic shock"No prior enrollment into this study
• Written informed consent

Where it is running

• University of California Davis Health System — Sacramento, California, United States
• Northwestern University — Chicago, Illinois, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Saint Vincent Hospital — Worcester, Massachusetts, United States
• Detroit Receiving Hospital — Detroit, Michigan, United States
• Sinai Grace Hospital — Detroit, Michigan, United States
• Henry Ford Health System — Detroit, Michigan, United States
• University of Mississippi Medical Center — Jackson, Mississippi, United States
• New York Methodist Hospital — New York, New York, United States
• Stony Brook University — New York, New York, United States
• Carolinas Medical Center — Charlotte, North Carolina, United States
• Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.